.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Daiichi Sankyo
Johnson and Johnson
Fish and Richardson
McKinsey
Argus Health
QuintilesIMS
UBS
Merck

Generated: June 24, 2017

DrugPatentWatch Database Preview

HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45% Drug Profile

« Back to Dashboard

Which patents cover Heparin Sodium 10,000 Units In Sodium Chloride 0.45%, and when can generic versions of Heparin Sodium 10,000 Units In Sodium Chloride 0.45% launch?

Heparin Sodium 10,000 Units In Sodium Chloride 0.45% is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45% is heparin sodium. There are seventy-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for Tradename: HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Clinical Trials: see list6,221
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45% at DailyMed

Pharmacology for Tradename: HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%
heparin sodium
INJECTABLE;INJECTION018911-001Jan 30, 1985DISCNNoNo► Subscribe► Subscribe
Hospira
HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%
heparin sodium
INJECTABLE;INJECTION018916-005Jan 31, 1984DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Merck
Mallinckrodt
Cipla
Healthtrust
McKesson
Baxter
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot